Close Menu

NEW YORK — DiaSorin Molecular said on Monday that it has received CE marking for its Simplexa Congenital CMV Direct kit for the detection of cytomegalovirus (CMV) DNA.

According to DiaSorin Molecular, Congenital CMV, which occurs when the virus is passed from mother to an unborn child, can led to severe and potentially fatal outcomes. Approximately 60,000 children are born each year in the US and EU with the infection, it said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.


This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.